Medication info
Rangaton Capsule 15mg (Lansoprazole)

Rangaton Capsule 15mg (Lansoprazole)

Prescription medicationHard capsuleOral
Ingredient · strength
Lansoprazole›15mg / 1 capsule
Manufacturer / importer
Kwangdong Pharmaceutical Co., Ltd.
Appearance
A hard capsule with a white to light brown granule, with a white upper and lower part.
Packaging
30 capsules/bottle
Approval status
Active

MFDS item code 201208079 · Approved 2012.11.09 · Insurance code 641805400

Summary

Main use
Peptic ulcer and Helicobacter pylori eradication, gastroesophageal reflux disease, treatment and prevention of gastric acid hypersecretion
Who takes it
Adults · Children
Adult dose
This medication should be administered before meals. For patients who have difficulty swallowing medication, open the capsule, mix this medication with a small amount (60mL) of orange or tomato juice, and administer immediately. Rinse the glass with twice as much juice or more to ensure the entire dose is taken, and drink immediately. Do not chew or crush this medication after opening the capsule. Short-term treatment of active duodenal ulcers: Administer lansoprazole 15mg orally once daily for 4 weeks. Short-term treatment of active benign gastric ulcers: Administer lansoprazole 30mg orally once daily for 8 weeks. Eradication of Helicobacter pylori to reduce recurrence of duodenal ulcers: Administer lansoprazole 30mg with clarithromycin 250 ~ 500mg and amoxicillin 1,000mg twice daily (every 12 hours) for 7 days. Treatment may be continued for up to 14 days if necessary. Eradication of Helicobacter pylori to reduce recurrence of duodenal ulcers: Administer lansoprazole 30mg with amoxicillin 1,000mg 3 times daily (every 8 hours) for 14 days. Maintenance therapy after treatment of duodenal ulcers: Administer lansoprazole 15mg orally once daily. Comparative clinical trials did not exceed 12 months. Treatment of nonsteroidal anti-inflammatory drug-induced gastric ulcers: Administer lansoprazole 30mg orally once daily for 8 weeks. Comparative clinical trials did not exceed 8 weeks. Reduction of the risk of nonsteroidal anti-inflammatory drug-induced gastric ulcers: Administer lansoprazole 15mg orally once daily for 12 weeks. Comparative clinical trials did not exceed 12 weeks. Short-term treatment of symptoms associated with gastroesophageal reflux disease: Administer lansoprazole 15mg orally once daily for 8 weeks. Short-term treatment of erosive reflux esophagitis: Administer lansoprazole 30mg orally once daily for 8 weeks. Maintenance therapy after treatment of erosive reflux esophagitis: Administer lansoprazole 15mg orally once daily. Pathological hypersecretory conditions, including Zollinger-Ellison syndrome: The dosage of lansoprazole for pathological hypersecretory conditions varies for each patient. The usual starting dose for adults is 60mg once daily. The dose should be adjusted according to the patient's needs and may be continued as long as it is clinically effective. Doses of 90mg twice daily have been administered. Daily doses exceeding 120mg should be given in divided doses. Because clearance of this medication is reduced in older adults, dose adjustment is necessary. Do not exceed a daily dose of 30mg. Because metabolism and excretion of this medication may be delayed in patients with hepatic impairment, administer with caution, including consideration of dose adjustment.
Child dose
Children and adolescents aged 12 ~ 17 years, short-term treatment of symptoms associated with non-erosive gastroesophageal reflux disease: 15mg once daily for 8 weeks Children and adolescents aged 12 ~ 17 years, short-term treatment of erosive reflux esophagitis: 30mg once daily for 8 weeks Children aged 1 ~ 11 years, 30kg or less: 15mg once daily for 12 weeks Children aged 1 ~ 11 years, over 30kg: 30mg once daily for 12 weeks

Ingredients

Manufacturer
Kwangdong Pharmaceutical Co., Ltd.

Efficacy & effects

Peptic ulcer and Helicobacter pylori eradication, gastroesophageal reflux disease, treatment and prevention of gastric acid hypersecretion

  • Active duodenal ulcer
  • active benign gastric ulcer
  • duodenal ulcer
  • NSAID-induced gastric ulcer
  • symptoms related to gastroesophageal reflux disease
  • erosive reflux esophagitis
  • Zollinger-Ellison syndrome
  • pathological hypersecretion states.
View approved original text

This medicine is used for the short term treatment of active duodenal ulcers and benign gastric ulcers. It is also effective in eradicating Helicobacter pylori to prevent the recurrence of duodenal ulcers. After treatment, it can be used for maintenance therapy of duodenal ulcers and erosive reflux esophagitis to prevent recurrence. It also helps in treating gastric ulcers caused by non-steroidal anti-inflammatory drugs and reducing the risk of their occurrence. It is used to temporarily relieve the symptoms of gastroesophageal reflux disease and erosive reflux esophagitis, and treats pathological hypersecretion states such as Zollinger-Ellison syndrome. This medication effectively manages gastric and esophageal diseases and improves symptoms.

How to take

Adult dose

This medication should be administered before meals. For patients who have difficulty swallowing medication, open the capsule, mix this medication with a small amount (60mL) of orange or tomato juice, and administer immediately. Rinse the glass with twice as much juice or more to ensure the entire dose is taken, and drink immediately. Do not chew or crush this medication after opening the capsule. Short-term treatment of active duodenal ulcers: Administer lansoprazole 15mg orally once daily for 4 weeks. Short-term treatment of active benign gastric ulcers: Administer lansoprazole 30mg orally once daily for 8 weeks. Eradication of Helicobacter pylori to reduce recurrence of duodenal ulcers: Administer lansoprazole 30mg with clarithromycin 250 ~ 500mg and amoxicillin 1,000mg twice daily (every 12 hours) for 7 days. Treatment may be continued for up to 14 days if necessary. Eradication of Helicobacter pylori to reduce recurrence of duodenal ulcers: Administer lansoprazole 30mg with amoxicillin 1,000mg 3 times daily (every 8 hours) for 14 days. Maintenance therapy after treatment of duodenal ulcers: Administer lansoprazole 15mg orally once daily. Comparative clinical trials did not exceed 12 months. Treatment of nonsteroidal anti-inflammatory drug-induced gastric ulcers: Administer lansoprazole 30mg orally once daily for 8 weeks. Comparative clinical trials did not exceed 8 weeks. Reduction of the risk of nonsteroidal anti-inflammatory drug-induced gastric ulcers: Administer lansoprazole 15mg orally once daily for 12 weeks. Comparative clinical trials did not exceed 12 weeks. Short-term treatment of symptoms associated with gastroesophageal reflux disease: Administer lansoprazole 15mg orally once daily for 8 weeks. Short-term treatment of erosive reflux esophagitis: Administer lansoprazole 30mg orally once daily for 8 weeks. Maintenance therapy after treatment of erosive reflux esophagitis: Administer lansoprazole 15mg orally once daily. Pathological hypersecretory conditions, including Zollinger-Ellison syndrome: The dosage of lansoprazole for pathological hypersecretory conditions varies for each patient. The usual starting dose for adults is 60mg once daily. The dose should be adjusted according to the patient's needs and may be continued as long as it is clinically effective. Doses of 90mg twice daily have been administered. Daily doses exceeding 120mg should be given in divided doses. Because clearance of this medication is reduced in older adults, dose adjustment is necessary. Do not exceed a daily dose of 30mg. Because metabolism and excretion of this medication may be delayed in patients with hepatic impairment, administer with caution, including consideration of dose adjustment.

Child dose

Children and adolescents aged 12 ~ 17 years, short-term treatment of symptoms associated with non-erosive gastroesophageal reflux disease: 15mg once daily for 8 weeks Children and adolescents aged 12 ~ 17 years, short-term treatment of erosive reflux esophagitis: 30mg once daily for 8 weeks Children aged 1 ~ 11 years, 30kg or less: 15mg once daily for 12 weeks Children aged 1 ~ 11 years, over 30kg: 30mg once daily for 12 weeks

Precautions

This medication should not be administered to patients with certain allergic reactions. For example, patients who are allergic to this medication or similar components, or who are hypersensitive to penicillin and macrolide antibiotics should not use it. Patients who are pregnant or have genetically determined lactose intolerance should also avoid taking this medication. Furthermore, patients with impaired liver function, elderly individuals, nursing mothers, and children should use this medication cautiously. This medication can rarely cause severe allergic reactions, blood abnormalities, liver dysfunction, serious skin reactions, etc., so if any abnormal symptoms occur during use, seek medical advice immediately. Long-term use may result in side effects such as vitamin B12 deficiency and hypomagnesemia, therefore regular checks are necessary. Additionally, there is an increased risk of fractures, so caution should be exercised during long-term use at high doses. This medication can interact with other drugs; therefore, it is essential to inform your physician or pharmacist, especially when used in conjunction with HIV medications, antibiotics, anticoagulants, and immunosuppressants. Symptoms such as dizziness or drowsiness may occur during administration, so caution is necessary while driving or operating machinery. In case of overdose, it cannot be removed by hemodialysis, so please visit a medical institution immediately to receive appropriate treatment. Store this medication out of reach of children, and do not transfer it to another container to maintain quality.

Side effects

Anaphylaxis, anaphylactic shock, angioedema, bronchospasm, acute interstitial nephritis, urticaria, generalized rash, facial edema, dyspnea, shock, pancytopenia, agranulocytosis, hemolytic anemia, granulocytopenia, thrombocytopenia, anemia, jaundice, elevated AST, elevated ALT, toxic liver dysfunction, toxic epidermal necrolysis, mucocutaneous syndrome, Stevens-Johnson syndrome, DRESS syndrome, interstitial pneumonia, fever, cough, abnormal lung sounds, interstitial nephritis, acute renal failure, membranous colitis, abdominal pain, frequent diarrhea, headache, diarrhea, abdominal distension, allergic reaction, back pain, weakness, candidiasis, cancer, chills, chest pain, edema, fever, flu-like symptoms, halitosis, infection, malaise, neck stiffness, pelvic pain, angina pectoris, arrhythmia, bradycardia, tachycardia, cerebrovascular accident, cerebral infarction, hypertension, hypotension, migraine, myocardial infarction, palpitations, vasodilation, syncope, asthma, bronchitis, increased cough, epistaxis, hemoptysis, hiccup, pneumonia, upper respiratory infection, laryngeal tumor, pulmonary fibrosis, pharyngitis, pleural disorders, respiratory disorders, rhinitis, sinusitis, wheezing, acne, alopecia, pruritus, rash, contact dermatitis, dry skin, nail disorders, skin cancer, skin diseases, sweating, abnormal vision, amblyopia, blepharitis, cataract, conjunctivitis, dry eyes, ear disorders, eye disorders, glaucoma, olfactory disturbances, photophobia, retinal degeneration, taste loss, blurred vision, deafness, ocular pain, otitis media, taste distortion, tinnitus, visual field constriction, urinary disorders, renal pain, penile disorders, testicular disorders, urethral pain, polyuria, frequency of urination, urinary retention, menstrual irregularities, chest tenderness, chest expansion, gynecomastia, diabetes, hematuria, erectile dysfunction, kidney stones, hepatotoxicity, vomiting, pancreatitis, taste disturbances, aplastic anemia, leukopenia, neutropenia, thrombocytopenic purpura, eosinophilia, hypomagnesemia, Clostridium difficile-associated diarrhea, fracture, myositis, erythema multiforme, acute generalized exanthematous pustulosis, speech disorders, urinary retention, increased AST, increased ALT, increased ALP, increased LDH, increased γ-GTP, weakness, hyponatremia, elevated total cholesterol, decreased total cholesterol, tongue paralysis, lip paralysis, limb paralysis, constipation, abdominal pain, dizziness, drowsiness, insomnia, paralysis, depressive state

Not everyone experiences these, and they can vary from person to person.

Storage

This medication should be stored in a tightly sealed container to avoid exposure to air or moisture. It should be stored at room temperature between 1°C and 30°C, away from extreme heat or cold.

Appearance and packaging

Appearance

A hard capsule with a white to light brown granule, with a white upper and lower part.

Package unit

30 capsules/bottle

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.